Trinity Biotech (TRIB) Misses Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. VZ
10. SPY

Go back to Trinity Biotech (TRIB) Misses Q3 EPS by 7c

Trinity Biotech Announces Q2 2023 Financial Results

October 3, 2023 9:15 AM EDT

DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Companys results for the quarter ended June 30, 2023.

Summary Highlights:

Revenue:

Total revenue for fiscal Q2, 2023 was $13.9m (excluding Fitzgerald Industries, which was disposed of in April 2023). Excluding our Covid focused PCR Viral Transport Media (VTM) products and Fitzgerald Industries, revenue for the quarter of $13.7m was 3% lower than... More